JP2002179587A - Indigo preparation effective for preventing/treating diabetes - Google Patents

Indigo preparation effective for preventing/treating diabetes

Info

Publication number
JP2002179587A
JP2002179587A JP2000404284A JP2000404284A JP2002179587A JP 2002179587 A JP2002179587 A JP 2002179587A JP 2000404284 A JP2000404284 A JP 2000404284A JP 2000404284 A JP2000404284 A JP 2000404284A JP 2002179587 A JP2002179587 A JP 2002179587A
Authority
JP
Japan
Prior art keywords
indigo
diabetes
stems
leaves
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000404284A
Other languages
Japanese (ja)
Inventor
Shinobu Matsuda
忍 松田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP2000404284A priority Critical patent/JP2002179587A/en
Publication of JP2002179587A publication Critical patent/JP2002179587A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide an indigo preparation and related composition effective for preventing/treating diabetes. SOLUTION: This indigo preparation is an extract from an indigo fermented product: 'Sukumo' obtained from an indigo dye manufacturing process using the leaves/stems of indigo belonging to the family Polygonaceae, or fine powder obtained by grinding the dried product of the leaves/stems and seeds of indigo by an appropriate means. This indigo preparation enables blood glucose to be controlled to a normal level as appropriate for not only patients suffered from diabetes but also those with slight diabetes, called persons with potential diabetes.

Description

【発明の詳細な説明】 (産業上の利用分野)この発明は、糖尿病の予防ならび
に治療に、初めて、タデ科植物の1種である藍調整物お
よびその組成物が利用可能であることを見出し完成させ
た。
DETAILED DESCRIPTION OF THE INVENTION (Industrial application field) The present invention finds that, for the first time, an indigo preparation, which is a kind of Polygonaceae, and a composition thereof can be used for prevention and treatment of diabetes. Completed.

(従来の技術及び課題)糖尿病の治療に関しては、近年
インスリン抵抗性改善薬が活用されるようになりつつあ
るが、しかしながらその副作用が問題となり、広く安心
して使えるようにはなり得ていない。 また、スルホニ
ル尿素剤、α−グルコシダーゼ阻害剤なども広く使われ
ているが、糖尿病の発症は年々増加の一途たどり、これ
ら薬剤も十分その役目を果たしているとはいえない状況
である。また植物由来のいくつかの成分が糖尿病に対し
て有効であるとの報告がなされているがその効果を十分
発揮しているとはいえない。本発明の課題は、糖尿病の
発症の予防ならびに治療に、極めて明瞭な効果を発揮す
る藍調整物ならびにその組成物を提供することにある。
(Prior art and problems) In the treatment of diabetes, insulin sensitizers have recently been used, but their side effects have become a problem, and they have not been able to be used widely and safely. In addition, sulfonylurea agents, α-glucosidase inhibitors, and the like are widely used, but the onset of diabetes is increasing year by year, and these agents are not sufficiently fulfilling their role. It has been reported that some plant-derived components are effective for diabetes, but it cannot be said that the effects are sufficiently exhibited. An object of the present invention is to provide an indigo preparation and a composition thereof which exhibit a very clear effect in preventing and treating the onset of diabetes.

(課題を解決するための手段)本発明者らは、古くから
解熱・解毒などの薬用に供されていたタデ科植物の1種
である「藍」に着目し研究を重ねた。その結果、藍調整
物ならびにその組成物は顕著にインスリンの分泌ならび
に受容体との相互作用の正常化を促がして、糖代謝を改
善し、より円滑にする作用のあることが確認された。
また、このものは極めて毒性が低く、糖尿病の予防なら
びに治療に安心して使うことができることをも確認し
た。
(Means for Solving the Problems) The present inventors have focused on "indigo" which is a kind of Polygonaceae plants that have been used for medicinal purposes such as antipyretic and detoxifying for a long time, and have repeatedly studied. As a result, it was confirmed that the indigo preparation and its composition markedly promote the normalization of insulin secretion and interaction with the receptor, thereby improving glucose metabolism and making it smoother. .
It has also been confirmed that this product has extremely low toxicity and can be used safely for the prevention and treatment of diabetes.

(作用)この発明における「藍調整物」とは、タデ科植
物「藍」の物理的または化学的処理による加工物全般を
抱合し、原料・製造方法は問わない。したがって、藍染
料の製造工程で作られる「すくも」と呼ばれる藍発酵
物、すなわち、藍の葉・茎が収穫され、きざまれ、乾燥
された後、水をかけて2−3ヶ月間発酵させると赤黒い
腐葉土のような形状になる、これを「すくも」と称し藍
調整物として利用可能である。この発明で用いる藍調整
物ならびに組成物の製造方法の概略は以下のごとくであ
る。
(Function) The "indigo preparation" in the present invention conjugates all processed products of the indigo plant "indigo" by physical or chemical treatment, regardless of the raw material and production method. Therefore, the indigo fermented product called "Sukumo", which is made in the process of producing indigo dye, that is, the leaves and stems of the indigo are harvested, chopped, dried, and then fermented for 2-3 months with water It is shaped like red-black humus, which is called "Sukumo" and can be used as an indigo preparation. The outline of the method for producing the indigo preparation and the composition used in the present invention is as follows.

「藍調整物・藍生素材」「すくも」を海洋深層水に約5
%になるように調整した後2日間浸漬する。これを遠心
分離し、上澄をミリポアフィルターでろ過して,除菌す
る。 これを「すくも溶液」と称する。
"Indigo preparation and indigo raw material" and "Sukumo" in deep ocean water for approx. 5
% And then immersed for 2 days. This is centrifuged, and the supernatant is filtered through a Millipore filter to remove bacteria. This is referred to as "scramble solution".

「藍調整物・藍加熱素材」「すくも溶液」を遠心分離
後、上澄をミリポアフィルターでろ過し除菌した後、さ
らに、110℃で10分間加熱滅菌する。これを、「加
熱すくも溶液」と称す 「藍乾燥葉・茎・種子粉末」収穫された藍の葉・茎・種
子を乾燥した後、微粉末に粉砕し、加圧・加熱滅菌す
る。 これを「藍乾燥葉・茎・種子粉末」と称する。
After centrifuging the "Indigo preparation / indigo heating material" and the "spider solution", the supernatant is filtered through a Millipore filter to remove bacteria, and further heat-sterilized at 110 ° C for 10 minutes. This is called a "heated spider solution.""Indigo dried leaves, stems, and seed powder." The harvested indigo leaves, stems, and seeds are dried, crushed into fine powder, and then pressurized and heat sterilized. This is referred to as "indigo dried leaves / stems / seed powder".

「藍組成物」糖尿病の予防・治療に効果のあることが伝
承されている他種植物、たとえば、ブラジル産Ciss
us sicyoides(インスリーナ Insul
ina)の葉・茎の乾燥物、ならびに藍の葉・茎・種子
の乾燥物を微粉末に粉砕後混合し、加圧・加熱滅菌す
る。これを「インスリーナ乾燥葉・茎・種子粉末」と称
する。
"Indigo composition" Other plants that have been reported to be effective in preventing and treating diabetes, for example, Ciss from Brazil
us sicyoides (Insulina Insul
ina) The dried product of leaves and stems and the dried product of indigo leaves, stems and seeds are pulverized into fine powders, mixed and then sterilized under pressure and heat. This is referred to as "insulina dried leaf / stem / seed powder".

実施例1 「藍生素材」藍の葉・茎混合物を適宜の大きさに裁断・
粉末化したのち3ヶ月間発酵させた「すくも」50gを
海洋深層水1リットルに浸漬した後、10,000rp
m で、10分間遠心分離する。 さらに、0.2ミリ
ミクロンのミリポアフィルターでろ過した後、「すくも
溶液」 約900mlを得る。これを、「すくも溶液」
と称して以下の試験に用いる。このものの固形物濃度
は、約1%であった。
Example 1 "Indigo raw material" Indigo leaf / stem mixture cut into appropriate size
50 g of "Sukumo" fermented for 3 months after pulverization was immersed in 1 liter of deep ocean water, and then 10,000 rpm
and centrifuge for 10 minutes. Further, after filtration through a 0.2 millimicron Millipore filter, about 900 ml of a "scoop solution" is obtained. This is called "Sukumo solution"
And used for the following tests. Its solids concentration was about 1%.

実施例2 「藍加熱素材」藍の葉・茎混合物を適宜の大きさに裁断
・粉末化したのち3ヶ月間発酵させた「すくも」:50
gを海洋深層水1リットルに浸漬した後、10,000
rpmで10分間遠心分離する。この上澄を 0.2ミ
リミクロンのミリポアフィルターでろ過して除菌した
後、さらに、110℃で10分間加熱滅菌する。これ
を、「加熱すくも溶液」と称して以下の試験に用いる。
Example 2 "Indigo heating material""Sukumo": A mixture of indigo leaves and stems was cut into a suitable size, powdered, and fermented for 3 months: 50
g in 1 liter of deep ocean water, then 10,000
Centrifuge at rpm for 10 minutes. The supernatant is sterilized by filtration through a 0.2 millimicron Millipore filter, and further sterilized by heating at 110 ° C. for 10 minutes. This is referred to as “heated spider solution” and used in the following tests.

実施例3 「藍乾燥葉・茎・種子粉末」収穫された藍の葉・茎・種
子を乾燥したものを粒子径約50ミクロン以下の微粉末
に粉砕し、110℃で10分間加圧・加熱滅菌する。こ
れを「藍乾燥葉・茎・種子粉末」と称する。
Example 3 "Indigo dried leaves, stems and seed powder" The harvested indigo leaves, stems and seeds were dried and ground into a fine powder having a particle size of about 50 microns or less, and pressed and heated at 110 ° C for 10 minutes. Sterilize. This is referred to as "indigo dried leaves / stems / seed powder".

実施例4 「インスリーナ乾燥葉・茎・種子粉末」ブラジル産Ci
ssus sicyoides〔 インスリーナ In
sulina 〕の葉・茎の乾燥物を粒子径約50ミク
ロン以下の微粉末に粉砕し、110℃で10分間加熱滅
菌する。これを「インスリーナ乾燥葉・茎・種子粉末」
と称する。
Example 4 "Insulina Dried Leaf / Stem / Seed Powder" Ci from Brazil
ssus sicoides [Insulina In
sulina] is dried to a fine powder having a particle size of about 50 μm or less, and sterilized by heating at 110 ° C. for 10 minutes. This is "Insulina Dried Leaves / Stem / Seed Powder"
Called.

(実施例5)実施例1で得た「すくも溶液」を用いて糖
尿病モデル動物における糖代謝に与える影響を調べた。
自然発症糖尿病モデルとして、Yellow kkマウ
スの8週齢(雄性)を2群に分け各群10匹に、「すく
も溶液」と深層海洋水(対照)とを4週間飲料水を与え
ずに任意に経口摂取させた。「すくも溶液」を投与した
マウスおよび深層海洋水を投与したマウスにそれぞれグ
ルコース2g/kgを糖負荷した後、60分,120分
後の血糖値およびインスリン値をそれぞれ測定したとこ
ろ「すくも溶液」を投与されたマウスでは、有意な血糖
値の低下が認められた(Table 1)。
(Example 5) The effect on glucose metabolism in a diabetic model animal was examined using the "splash solution" obtained in Example 1.
As a spontaneous diabetes model, 8-week-old (male) Yellow kk mice were divided into two groups, and 10 mice in each group were given a "drip solution" and deep seawater (control) arbitrarily without drinking water for 4 weeks. Oral ingestion. After glucose load of 2 g / kg of glucose was applied to each of the mice to which the “sukumo solution” was administered and the mice to which deep sea water was administered, the blood glucose level and the insulin level after 60 minutes and 120 minutes were measured. In the administered mice, a significant decrease in blood glucose level was observed (Table 1).

(実施例6)自然発症糖尿病モデルマウスC57BL/
KsJ−db/db 7週齢雌性を2群に分け各群10
匹に「加熱すくも溶液(1%)」(200mg/kg)
と深層海洋水とを4週間飲料水を与えずに任意に経口摂
取させた。投与終了後グルコース 2g/kg を糖負
荷した後、60分、120分の血糖値およびインスリン
値をそれぞれ測定したところ、「加熱すくも溶液」を摂
取したマウスでは有意な血糖値の低下が認められた(T
able 2)。
(Example 6) Spontaneous diabetes model mouse C57BL /
KsJ-db / db Seven-week-old females were divided into two groups and each group contained 10
"Hot spider solution (1%)" (200mg / kg)
And deep sea water were orally ingested without drinking water for 4 weeks. After glucose administration with 2 g / kg of glucose after the end of the administration, the blood glucose level and the insulin level were measured for 60 minutes and 120 minutes, respectively. As a result, a significant decrease in the blood glucose level was observed in the mouse that took the “heated spider solution”. (T
able 2).

実施例7 臨床試験は2型糖尿病患者予備群を対象にして実施し
た。これらの患者予備群の人達は食事療法と運動療法を
併用している方々で医薬品の服用はされていなかった。
患者予備群30人の背景は年齢平均55±8歳 体重6
7±4kg BMI:24±6kg/mであった。こ
の患者予備群を2群に分けそれぞれプラセボ服用群(対
照)と「加熱すくも溶液」(3ml)服用群、各15人
づつとした。それぞれ8週間、1日3回(朝食後、午後
3時、就寝前に各1ml)服用した。その結果、「加熱
すくも溶液」服用群において、空腹時血糖値およびHb
A1cの低下が認められた(Table 3)。
Example 7 A clinical test was conducted on a preliminary group of patients with type 2 diabetes. The patients in these patients were on a diet and exercise regimen that had not taken any medications.
The background of the 30 patients in the reserved group is the average age 55 ± 8 years old Weight 6
7 ± 4 kg BMI: 24 ± 6 kg / m 2 . The preliminary patient group was divided into two groups, and a placebo group (control) and a “heated spider solution” (3 ml) group were used, each having 15 patients. They were taken three times a day for 8 weeks each (after breakfast, 3 pm, 1 ml each before bedtime). As a result, the fasting blood sugar level and Hb
A1c was reduced (Table 3).

実施例8 実施例3で得られた「藍乾燥葉・茎・種子粉末」を用い
て、その食後過血糖を抑制する効果を以下の如く確認し
た。7週齢Wister系雄性ラットを2群に分け各群
7匹の一方を非投与対照群とし、他方に「藍乾燥葉・茎
・種子粉末」(100mg/kg)を、それぞれ強制経
口投与したのち、1時間後に両群にグルコース 2g/
kgを糖負荷し、120分後の血糖値およびインスリン
値を測定した。 「藍乾燥葉・茎・種子粉末」を投与
した群では有意な血糖値の低下が認められた(Tabl
e 4)。
Example 8 The effect of suppressing postprandial hyperglycemia was confirmed as follows using the indigo dried leaf, stem, and seed powder obtained in Example 3. Seven-week-old male Wistar rats were divided into two groups, one of each of which was a non-administration control group, and the other was administered with "indigo dried leaf / stem / seed powder" (100 mg / kg) by oral gavage. 1 hour later, both groups had glucose 2 g /
The kg was loaded with glucose, and the blood glucose level and insulin level 120 minutes later were measured. A significant decrease in blood glucose level was observed in the group to which "blue-dried leaves / stems / seed powder" was administered (Tabl)
e 4).

実施例9 実施例4で得られた「インスリーナ乾燥葉・茎・種子粉
末」を用いて、その食後過血糖を抑制する効果を以下の
如く確認した。8週齢Wister系雄性ラットを2群
に分け各群7匹の一方を非投与対照群とし、他方に「イ
ンスリーナ乾燥葉・茎・種子粉末」(150mgkg)
をそれぞれ強制経口投与したのち、1時間後に両群にグ
ルコース 2g/kgを糖負荷し、120分後の血糖値
およびインスリン値を測定した。「インスリーナ乾燥葉
・茎・種子粉末」を投与した群では、明らかに血糖値の
上昇が抑制されているのが認められた(Table
5)。
Example 9 The effect of suppressing postprandial hyperglycemia was confirmed using "insulina dried leaves / stalks / seed powder" obtained in Example 4 as follows. Eight-week-old male Wistar rats were divided into two groups, one of which was a non-administration control group, and the other was "Insulina dried leaf / stem / seed powder" (150 mg kg).
Was administered by gavage, and 1 hour later, both groups were glucose-loaded with 2 g / kg of glucose, and the blood glucose level and insulin level 120 minutes later were measured. In the group to which “Insulina dried leaves / stem / seed powder” was administered, an increase in blood glucose level was clearly suppressed (Table).
5).

本発明において 糖尿病モデルを用いた動物実験ならび
にヒト臨床試験の結果から藍調整物及びその組成物は糖
尿病の予防ならびに治療に十分な効果を発揮することが
確認された。特にインスリンの働きならびに受容体との
相互作用などの正常化をうながして、糖代謝を改善し、
より円滑に代謝されていることが明瞭に示されたと考え
る。
In the present invention, the results of animal experiments and human clinical tests using a diabetes model confirmed that the indigo preparation and its composition exerted a sufficient effect on the prevention and treatment of diabetes. In particular, it promotes the normalization of the action of insulin and the interaction with the receptor, improving glucose metabolism,
It is considered that metabolism was more clearly shown.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) C09B 61/00 C09B 61/00 Z ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat ゛ (Reference) C09B 61/00 C09B 61/00 Z

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】タデ科植物に属する藍の葉・茎から藍染料
製造工程で作られる「すくも」の抽出物
1. An extract of "Sukumo" which is produced from indigo leaves and stems belonging to the Polygonaceae family in the process of producing indigo dye
【請求項2】タデ科植物に属する藍の葉・茎および種子
の乾燥物を適宜の手段で粉砕した微粉末
2. A fine powder obtained by crushing dried indigo leaves, stems and seeds belonging to the Polygonaceae plant by an appropriate means.
JP2000404284A 2000-12-14 2000-12-14 Indigo preparation effective for preventing/treating diabetes Pending JP2002179587A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000404284A JP2002179587A (en) 2000-12-14 2000-12-14 Indigo preparation effective for preventing/treating diabetes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000404284A JP2002179587A (en) 2000-12-14 2000-12-14 Indigo preparation effective for preventing/treating diabetes

Publications (1)

Publication Number Publication Date
JP2002179587A true JP2002179587A (en) 2002-06-26

Family

ID=18868265

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000404284A Pending JP2002179587A (en) 2000-12-14 2000-12-14 Indigo preparation effective for preventing/treating diabetes

Country Status (1)

Country Link
JP (1) JP2002179587A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013213018A (en) * 2012-03-09 2013-10-17 Sunstar Inc Composition containing indigo plant extract and mugwort extract

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013213018A (en) * 2012-03-09 2013-10-17 Sunstar Inc Composition containing indigo plant extract and mugwort extract

Similar Documents

Publication Publication Date Title
Shapiro et al. Natural products used for diabetes
CN105530928B (en) Prevent and treat the pharmaceutical composition of the fat and fat metabolic syndrome induced
JP2020172523A (en) Eurycoma longifolia extract and its use in enhancing and/or stimulating immune system
JPWO2007086100A1 (en) Composition having blood pressure lowering action and / or elevation suppressing action and food and drink containing the same
CN1935010B (en) Health food for intensifying body immunological competence and improving memory function, and its preparing method
JP2001342142A (en) Composition for preventing and curing urologic disease
JP2014031367A (en) Sympathetic nerve activator
EP1583547B1 (en) Anti-obesity ingredients from medicinal plants and their composition
JP2007308426A (en) Ointment for ameliorating or treating tumor in oral cavity
EP2603211B1 (en) Composition for treating hyperlipidemia
CN104383244B (en) It is a kind of to treat Chinese medicine composition of cancer of the esophagus and preparation method thereof
Muruganantham et al. Gums as Pharmaceutical Excipients: An Overview
Hassan et al. Wheat Grass (Triticum aestivum L.) Benefits Health in a Pandemic Scenario
KR20170095646A (en) Manufacturing method of composition having anti-diabetic effect containing the extracts of fermented germinated brown rice and orstachys japonia
WO2014134833A1 (en) Edible composition, preparation method therefor, and food product comprising the composition
CN106309758B (en) Pharmaceutical composition for resisting gastrointestinal cancer
JP2002179587A (en) Indigo preparation effective for preventing/treating diabetes
WO2022272314A1 (en) Medicine composition for treatment of bone and joint diseases originated from medicinal materials and the process for producing thereof
WO2016072507A1 (en) PROPHYLACTIC OR THERAPEUTIC AGENT FOR PEPTIC ULCER, FOOD ADDITIVE FOR PROPHYLACTIC OR THERAPEUTIC USE, iNOS EXPRESSION INHIBITOR AND COX-2 EXPRESSION INHIBITOR
JP2002255837A (en) Aldose reductase inhibitor
JP7016074B2 (en) Composition for reducing triglycerides and cholesterol
CN106591058A (en) Propolis wine capable of enhancing immunity and preparation method thereof
KR20160082568A (en) Composition comprising Rhus verniciflua for extraction and extraction mthod of the Composition
JPH1149690A (en) Composition for stimulating lipolysis
JP2009062348A (en) Hypoglycemic action and blood sugar level elevation-suppressive action by seed ingredient of kenafs (kenaf and roselle)